NCT03864445View on ClinicalTrials.gov

Phosphate Binder-combination Study of KHK7791 in Hyperphosphatemia Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

April 29, 2019

Primary Completion Date

December 3, 2019

Study Completion Date

December 3, 2019

Conditions
Hyperphosphatemia
Interventions
DRUG

KHK7791

oral administration

DRUG

Placebp

oral administration

Trial Locations (1)

Unknown

Study Site 1, Chiba

All Listed Sponsors
lead

Kyowa Kirin Co., Ltd.

INDUSTRY

NCT03864445 - Phosphate Binder-combination Study of KHK7791 in Hyperphosphatemia Patients | Biotech Hunter | Biotech Hunter